Emtricitabine + Rilpivirine + Tenofovir Disoproxil
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Emtricitabine
emtricitabine - Rilpivirine
rilpivirine - Tenofovir Disoproxil
tenofovir-disoproxil
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tabletsES GB | 200 mg / 25 mg / 245 mg | Gilead Sciences Ltd |
| COMPLERACA US |
| GILEAD SCIENCES CANADA INC |
| emtricitabine, rilpivirine and tenofovir disoproxil fumarateUS | 200 mg / 25 mg / 300 mg | Laurus Labs Limited |
| emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarateUS | 200 mg / 25 mg / 300 mg | Gilead Sciences, Inc. |
| Emtricitabine, Rilpivirine, Tenofovir Disoproxil FumarateUS | 200 mg / 25 mg / 300 mg | Mylan Pharmaceuticals Inc. |
| emtricitabina + rilpivirina + tenofovirES | 200 mg / 25 mg / 245 mg | Gilead Sciences Ireland Unlimited Company |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- ES · EVIPLERA · 1 products · record
- GB · EVIPLERA · 2 products · record
- US · COMPLERA · 3 products · record
- CA · COMPLERA · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.